Takeda Pharmaceutical Stock Quote TAKP34 - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
Brazil
BOV
Takeda Pharmaceutical Co (TAKP34) Quote

Takeda Pharmaceutical Co (TAKP34)

72.31

0.00

(0.00%)

Closed June 16 4:55PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

72.31

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

66.46 52 Week Range 79.55

Market Cap

Previous Close

72.31

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

158

Shares Outstanding

1,582,393,000

Dividend Yield

-

PE Ratio

0.54

Earnings Per Share (EPS)

91.04

Revenue

4.28T

Net Profit

144.07B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.takeda.co.jp

Headquarters

Chuo, Tokyo, Jpn

Founded

1984

Takeda Pharmaceutical Co is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker TAKP34. The last closing price for Takeda Pharmaceutical was R$72.31. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of R$ 66.46 to R$ 79.55.

Takeda Pharmaceutical currently has 1,582,393,000 shares outstanding. The market capitalization of Takeda Pharmaceutical is R$78.09 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 0.54.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.63	0.87890625	71.68	72.31	71.68	6	72.2575	DR
4	4.2	6.16649537513	68.11	72.31	67.08	78	67.78966318	DR
12	0.41	0.570236439499	71.9	72.31	66.46	158	68.61060944	DR
26	3.42	4.96443605748	68.89	74.2	66.46	95	69.72758147	DR
52	-5.58	-7.16394915907	77.89	79.55	66.46	63	70.05102096	DR
156	-13.82	-16.0455125972	86.13	92	66.01	114	78.50021116	DR
260	-10.47	-12.6479826045	82.78	109.9	65.9	393	88.05429431	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KAVLKaival Brands Innovations Group Inc	$ 5.96 (338.24%)	70.99M
LRHCLa Rosa Holdings Corporation	$ 1.165 (90.61%)	40.6M
SVMHSRIVARU Holding Ltd	$ 0.227586 (49.24%)	276.03M
BRFHBarfresh Food Group Inc	$ 3.03 (38.36%)	247.31k
NNENano Nuclear Energy Inc	$ 9.37 (32.53%)	1.77M
NXLNexalin Technologies Inc	$ 0.89 (-35.52%)	3.93M
INABIN8bio Inc	$ 1.095 (-34.82%)	4.92M
QXOQXO Inc	$ 134.10 (-34.71%)	142.29k
GANXGain Therapeutics Inc	$ 1.24 (-34.39%)	3.09M
KYTXKyverna Therapeutics Inc	$ 9.52 (-34.07%)	4.31M
NVDANVIDIA Corporation	$ 131.88 (1.75%)	309.34M
SVMHSRIVARU Holding Ltd	$ 0.227586 (49.24%)	276.03M
KITTNauticus Robotics Inc	$ 0.1921 (19.69%)	165.83M
CRKNCrown Electrokinetics Corporation	$ 0.0582 (-21.35%)	136.77M
SQQQProShares UltraPro Short QQQ	$ 8.43 (-1.29%)	112.46M

bas2020

bas2020 1 minute ago

Indeed... the script of collusive manipulation by your handlers. 👺

sundoctor

sundoctor 2 minutes ago

you make sense? delete others posts, one post for long long time......please post the notice you get from SEC showing you submit the complaint.

satter

satter 2 minutes ago

That is hilarious!

janice shell

janice shell 2 minutes ago

That is true. Eeeeuuuwww.

Imokurok

Imokurok 2 minutes ago

I too received a phone call today here in Canada inquiring why I have not voted and took my approval votes over the phone. How can someone
else put in my vote without proper documentation. I have not received anything in my mail or email from NWBO to vote. Anybody have any advise

Zorax

Zorax 3 minutes ago

That's a wonderful thing.
It's just me, but I would have gone with a little more upbeat color scheme however.
But if the paint was free.....

12yearplan

12yearplan 3 minutes ago

Cool Zor - good deep dive. The hockey spirit I related to. Too bad they weren't real.

BIOChecker4

BIOChecker4 3 minutes ago

There is no conspiracy. If Biogen/Eisai and Lilly thought Anavex had technology that was a threat to their AD franchise, one or the other would have bought the company a long time ago (Biogen had the chance but passed on moving forward with Anavex). Money would have been no object. This is how it wo

cojoboy

cojoboy 3 minutes ago

Like I stated.. The ones who feel the need to brag..got nothing.. But..eenie..weenie..tiny..nothing..😂😂😂

cjstocksup

cjstocksup 4 minutes ago

https://x.com/GenFlynn/status/1802009694665367592

cjstocksup

cjstocksup 4 minutes ago

https://x.com/TaraBull808/status/1802067600064844025

12yearplan

12yearplan 6 minutes ago

For sure, but unless there is an obvious agenda (which I don't see) it's a conversation starter. Stress all around one can't argue with.

LuckyLovie

LuckyLovie 7 minutes ago

Alot read em...I get many private notes yelling at me...so u wrong guy who can't spell his own name...lol
Wait you read my posts

It's ok I love me Some me and my girl smothered me from 6am til 6pm 6 rounds I cannot survive...so I come here she thinks it's work,so I can catch a

cojoboy

cojoboy 7 minutes ago

Well..I'll pop for the the peanuts..these clowns can't hang with us that's why they resort to attacking us..stay the course...👌👌👌👌

DewDiligence

DewDiligence 8 minutes ago

...I do wonder what the effect of having extra drug in the eye for 2-3 months is...Seems like a legitimate concern! ...if successful, the OCUL re-dose trial should be fantastic commercially. I suppose so, but redosing a 9-month implant after 6 months might send a confusing message.

johnnytrader33

johnnytrader33 8 minutes ago

anyone receive their dividends yet???? HAHAHAHAHHAHA RRIIGGHHTTT.....

XenaLives

XenaLives 8 minutes ago

More on the Black Box that is FDA pharma approval... (pun intended).

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174608416

Slojab

Slojab 8 minutes ago

And that pr contained these comments from Miller. Knowing what's transpired since, they're beyond laughable. So, don't believe anything Tony says.

According to Anthony Miller, CEO, This is the 3rd dividend that the company has issued to its shareholders in recent years… and this ev

cjstocksup

cjstocksup 8 minutes ago

https://x.com/CollinRugg/status/1802102303937425525

kym1216

kym1216 9 minutes ago

What's nice is this has been just one person liquidating. It all points to Mark Munro but I have noticed the O/S has remained the same during this period of high volume. There was also heavy shorting. I think you are correct, this will pop back to .10 pretty quick. It would be nice to see a couple

thegoodnessparadox

thegoodnessparadox 9 minutes ago

The magic theme is part of the surprise.

dukeb

dukeb 9 minutes ago

Being with Kimberly is a special kind of humiliation. It's a fetish.

Sogo

Sogo 9 minutes ago

Very interesting laundry list there. Thank you! Hadn’t thought of many of those.

Takeda Pharmaceutical

Beyond Protocol

Beyond Protocol

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions